Iluka Resources Limited

As of December 31, 2025, Iluka Resources Limited carries a market capitalization of 1.44B, placing it among publicly traded companies globally. Its enterprise value stands at 2.06B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Iluka Resources Limited's next confirmed earnings release is scheduled for February 23, 2027.

As of December 31, 2025, Iluka Resources Limited has 429.65M shares outstanding.

These figures are as of December 31, 2025. The price-to-sales ratio is 2.49, and the price-to-book ratio stands at 1.22.

These figures are as of December 31, 2025. The EV/Sales ratio of 3.57 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 2.06B versus a market cap of 1.44B, with the gap driven by net debt and cash on the balance sheet.

As of December 31, 2025, Iluka Resources Limited maintains a current ratio of 3.51, meaning it holds 3.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 54.98, indicating elevated leverage, while an interest coverage ratio of -8.98 demonstrates limited ability to service its debt obligations.

Over the twelve months ended December 31, 2025, Iluka Resources Limited posted a negative return on equity (ROE) of -13.02, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -7.24, reflecting losses generated across the asset base. The company generates approximately 634,618.99 in revenue per employee across its workforce of 909.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 0.52 indicates how many times Iluka Resources Limited sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended December 31, 2025, Iluka Resources Limited recorded an income tax benefit of -78.86M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -242.70M and -163.85M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on August 28, 2026, Iluka Resources Limited's stock has gained approximately 26.20% over the past 52 weeks. The 50-day moving average sits at 4.12, while the 200-day moving average is 4.04.

Over the twelve months ended December 31, 2025, Iluka Resources Limited generated 576.87M in revenue and converted that into -163.85M in net income, yielding earnings per share of -0.38. EBITDA reached -96.47M, while operating income came in at 86.47M.

As of December 31, 2025, Iluka Resources Limited holds 25.96M in cash and equivalents against 646.24M in total debt, resulting in a net debt position of 600.28M. Total book value stands at 1.18B, with working capital of 475.80M providing operational flexibility.

These figures cover the twelve months ended December 31, 2025.

Over the twelve months ended December 31, 2025, Iluka Resources Limited posted a gross margin of 59.74, reflecting its pricing power and cost economics. The operating margin of 14.99 and net profit margin of -28.40 provide insight into operational efficiency.

Over the twelve months ended December 31, 2025, Iluka Resources Limited paid dividends of 0.03 per share. The dividend payout ratio of -8.74 is negative because earnings are negative, so the dividend is being paid out of something other than profits, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Total shareholder yield is negative at -31.04, meaning Iluka Resources Limited raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Iluka Resources Limited's most recent stock split took place on March 19, 2008.

As of December 31, 2025, Iluka Resources Limited has an Altman Z-Score of 1.59, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.